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A 30 Å long U-shaped catalytic tunnel in the crystal structure of
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Background: Polyamines are essential for cell growth and differentiation;
compounds interfering with their metabolism are potential anticancer agents.
Polyamine oxidase (PAO) plays a central role in polyamine homeostasis. The
enzyme utilises an FAD cofactor to catalyse the oxidation of the secondary
amino groups of spermine and spermidine.
Results: The first crystal structure of a polyamine oxidase has been determined
to a resolution of 1.9 Å. PAO from Zea mays contains two domains, which define
a remarkable 30 Å long U-shaped catalytic tunnel at their interface. The structure
of PAO in complex with the inhibitor MDL72527 reveals the residues forming the
catalytic machinery and unusual enzyme-inhibitor CH...O H bonds. A ring of
glutamate and aspartate residues surrounding one of the two tunnel openings
contributes to the steering of the substrate towards the inside of the tunnel.
Conclusions: PAO specifically oxidises substrates that have both primary and
secondary amino groups. The complex with MDL72527 shows that the primary
amino groups are essential for the proper alignment of the substrate with
respect to the flavin. Conservation of an N-terminal sequence motif indicates
that PAO is member of a novel family of flavoenzymes. Among these,
monoamine oxidase displays significant sequence homology with PAO,
suggesting a similar overall folding topology.
Introduction
Spermidine and spermine are polyamine molecules essen-
tial for cell proliferation and differentiation [1,2]. It is well
known that polyamines bind DNA. Moreover, some pro-
teins such as the insulin receptor, protein kinase CK2,
certain potassium channels and N-methyl-D-aspartate
(NMDA) receptors possess a specific polyamine-binding
site, possibly having a regulatory function [3,4,5]. Growing
evidence arises indicating that polyamine catabolism in
plants is associated with physiological events such as lig-
nification, cell-wall stiffening and cellular defence [6,7].
Polyamine levels are controlled by a major regulatory
system that includes pathways for polyamine biosynthesis
and degradation as well as for their transport across the
cell membrane.
Polyamine oxidase (PAO) catalyses the oxidation of the
secondary amino groups of polyamines (Figure 1a). The
exact nature of the reduction product depends on the
source of the enzyme. Animal PAO transforms spermidine
and spermine into putrescine (1,4-diaminobutane) and
spermidine, respectively, plus 3-amino-propionaldehyde.
Conversely, plant and bacterial polyamine oxidases catal-
yse the conversion of spermidine and spermine to 4-amino-
butyraldehyde and 3-aminopropyl-4-aminobutyraldehyde,
respectively, plus 1,3-diaminopropane [7] (Figure 1b).
Despite these differences, the plant, bacterial and animal
polyamine oxidases essentially share identical molecular
properties. PAO is a monomeric soluble protein with a mol-
ecular mass of about 53 kDa and a non-covalently bound
FAD molecule as cofactor [8]. As typically observed in
flavin-dependent oxidases, the overall reaction catalysed
by PAO can be divided into a reductive half reaction, in
which the flavin is reduced upon polyamine oxidation, and
an oxidative half reaction, in which the reduced flavin is
reoxidised by molecular oxygen with the release of hydro-
gen peroxide (Figure 1a). Polyamine oxidation results in
the formation of an imino compound, which is hydrolysed
to produce the final products (Figure 1a) [7,8].
PAO is a key enzyme in the polyamine catabolic
pathway. The interest in polyamine metabolism has
increased with the discovery that some polyamine ana-
logues show antitumoral effect on a number of cell lines
[9]. Although the precise mechanism of the cytotoxic
activity is not known, it has been noticed that the accu-
mulation of these analogues leads to DNA fragmentation
and cell death by apoptosis [10]. PAO plays a crucial role
in these processes. For instance, some of the polyamine
analogues, such as N1-ethyl-N11-[(cyclopropyl)methyl]-
4,8-diazaundecane, can induce programmed cell death
by increasing polyamine catabolism and inducing the
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consequent production of toxic H2O2 [11]. Progress in the
analysis of the metabolism of these antineoplastic com-
pounds is a promising route for the design of new drugs
for the treatment of cancer [2].
In the framework of a project devoted to the analysis of the
functional properties of flavoenzymes [12,13], we have
carried out the structure determination of PAO from Zea
mays L. in the native state and in complex with MDL72527,
a widely used inhibitor of the enzyme (Figure 1c). Com-
pared to animal PAO, the maize protein offers the advan-
tage that it can be purified from plant leaves in sufficiently
large quantities to carry out enzymological characterisation
and crystallisation experiments. Furthermore, the maize
enzyme represents the first PAO of known primary struc-
ture [6,7]. The X-ray analysis reveals that the overall topol-
ogy of PAO resembles that of other flavoproteins and
reveals a remarkable U-shaped catalytic tunnel, which
extends throughout the structure.
Results and discussion
Structure determination
The X-ray crystal structure of native PAO from Zea mays
L. has been determined at 1.9 Å resolution by multiple
isomorphous replacement (MIR) combined with solvent
flattening and threefold averaging. After refinement, the
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Substrates and inhibitor of PAO. (a) Scheme of spermidine-oxidation
reaction catalysed by PAO from Zea mays. (b) Oxidation of spermine
and spermidine with their relative reaction products. Labels A and B
indicate the site of enzymatic attack in the mammalian and plant/bacterial
PAO, respectively. (c) Chemical structure and atom numbering of the
inhibitor N,N’-bis(2,3-butadienyl)-1,4-butane-diamine (MDL72527).
final model has an R factor of 19.9% for 216,570 reflections
to the resolution of 1.9 Å and a free R factor of 23.4% for
2000 randomly chosen reflections (see Figure 2 and
Table 1). The Ramachandran plot for the three crystallo-
graphically independent subunits shows that 90.3% of the
residues are in the most favoured regions and 9.4% in
additionally allowed regions. Only Asp351, which belongs
to a type II′ turn connecting Sβ5 to Sα4 (Figure 3a), is
outside the allowed regions, the conformation of this
residue being unambiguously defined in the electron-
density map. The native structure has been used as an
initial model for the refinement of the PAO–MDL72527
complex, which has been refined to an R factor of 19.3%
for 211,025 reflections up to 1.9 Å resolution and a free R
factor of 22.9% (Table 1).
The asymmetric unit of the crystals contains three PAO
subunits (named A, B and C). In the description of the
structure we refer to subunit C, as it displays a slightly
lower average B factor for the protein atoms (14.7 Å2) in
comparison with the other two subunits (17.6 Å2 and
15.7 Å2 for subunits A and B, respectively). However, the
three subunits are essentially identical, with root mean
square (rms) deviations between subunits A and C and
subunits B and C of 0.21 Å and 0.31 Å, respectively, for
459 Cα atom pairs.
The overall structure
Maize PAO is a 53 kDa monomeric enzyme [7] consisting
of 13 α helices and 19 β strands, which fold to form two
well-defined domains (Figures 3a, 3b and 4). The FAD-
binding domain comprises three fragments (residues 7–87,
187–292 and 412–466) whose main structural elements are
a central parallel β sheet (strands Fβ1, Fβ2, Fβ11 and
Fβ13) flanked by a β meander (Fβ8, Fβ9, Fβ10 and Fβ12)
and three α helices (Fα1, Fα8 and Fα4). This arrangement
corresponds to the classical folding topology observed in
several dinucleotide-binding enzymes [14]. The substrate-
binding domain is composed of two fragments (residues
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Figure 2
Fobserved–Fcalculated omit map of the MDL72527
inhibitor. The map is contoured at the 3σ level.
Structure
Table 1
Refinement statistics.
Native MDL72527
Resolution range (Å)* 100.0–1.9 100.0–1.9
Number of protein atoms†
subunit A 3766 3780
subunit B 3797 3811
subunit C 3821 3835
Rmsd for NCS restraints (Å)‡
subunit A–subunit B 0.29 0.29
subunit B–subunit C 0.31 0.28
subunit A–subunit C 0.21 0.20
Number of water molecules 678 629
R factor (%)§ 19.9 19.3
Rfree (%; 2000 reflections) 23.4 22.9
Rmsd from ideal values‡
bond lengths (Å) 0.013 0.011
bond angles (°) 2.252 2.262
trigonal atoms (Å) 0.013 0.014
planar group (Å) 0.015 0.018
non-bonded atoms (Å) 0.106 0.136
*All measured reflections were used for refinement (no σ cut-off). †Out
of a total of 472 amino acids for each monomer, subunit A comprises
residues 5–463, whereas subunits B and C include residues 5–466.
‡Root mean square deviations calculated for 459 Cα atom pairs. The
rmsds from ideal values were calculated using the program TNT [39].
NCS restraints were applied to the three subunits during refinement.
§R factor = Σ || Fobs | – | Fcalc || / Σ | Fobs |. The indicated value refers to
the final R factor as calculated for all reflections (including those
omitted for Rfree calculation). 
88–186 and 293–411) and is characterised by a six-stranded
mixed β sheet flanked by five α helices. The two domains
create a tunnel that defines the enzyme active centre at
their interface (Figures 5a and 5b).
The folding topology of PAO resembles that of other
flavoenzymes such as p-hydroxybenzoate hydroxylase
[15,16], cholesterol oxidase [17], glucose oxidase [18] and
D amino acid oxidase [19,20]. The most closely related
structure is that of p-hydroxybenzoate hydroxylase, which
displays an rms deviation from PAO of 3.9 Å for 217 Cα
atom pairs (the sequence identity for the equivalent
residues is 15%). The similarity is particularly evident in
the FAD-binding domain, the sole divergence being due
to residues 47–57 that in PAO form an antiparallel β sheet
(Fβ3 and Fβ4, Figures 3a and 4) absent in p-hydroxyben-
zoate hydroxylase. More consistent structural variations
occur at the substrate-binding domain. The β sheet at the
heart of this domain is essentially conserved but the sec-
ondary structures around it are quite different. In particu-
lar, the major deviation involves residues 95–192 and
313–330, which form five α helices (Sα1, Sα2, Sα3, Sα4
and Sα5) that surround one side of the catalytic tunnel
(Figures 3a and 5a).
PAO is a glycosylated enzyme [21]; the electron-density
map shows that the glycosylation site is Asn77. In subunit
C, a branched chain of five ordered sugars, two N-acetyl-D-
glucosamine residues as well as a fucose and two mannose
residues have been modelled (not shown). The electron-
density map at the glycosylation site of subunits A and B is
less well-defined and only two N-acetyl-D-glucosamine
residues could be modelled. So far, the role of glycosylation
in PAO has not been established, although the glycosidic
residues are likely to represent a secretion signal related to
the apoplastic localisation of the enzyme [7].
The FAD-binding site
The FAD prosthetic group is non-covalently bound to
the protein and is deeply embedded within the structure
(Figures 3b and 5a). All FAD atoms are solvent-inacces-
sible, with the exception of the flavin C5a, N5 and C4a
atoms that line the active centre. The binding mode and
the conformation of the ADP-ribityl fragment of the
cofactor is very similar to that observed in the enzymes
sharing the dinucleotide-binding fold [14]. The main
features are (Figure 6): the H bonds between the N1 and
N6 atoms of the adenine ring with the backbone atoms
of Val237, at the beginning of Fβ8; the interactions of
Glu35 and Tyr399 sidechains with the hydroxyl groups
of the ribose; the compensation of the pyrophosphate
negative charges by the backbone nitrogen and sidechain
of Arg43, the mainchain nitrogen of Glu430 and the N
terminus of helix Fα1 (Ser15); and the involvement in
the ADP-ribityl binding of seven ordered water mol-
ecules, present in the three crystallographically indepen-
dent subunits of both native and PAO–MDL72527
complex structures.
The isoalloxazine ring is located at the interface of the
two domains, with the re side facing the inner part of the
substrate-binding site (Figures 5a and 7). The flavin
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Figure 3
The overall structure of PAO. (a) MOLSCRIPT [42] diagram of the
maize PAO subunit. The secondary structure elements of the FAD-
binding domain are labelled with the letter F followed by numbers,
according to their order in the sequence. Similarly, helices and 
β strands of the substrate-binding domain are indicated by the letter S,
followed by sequential numbers. Labels N and C indicate the 
N terminus and C terminus, respectively. (b) Stereo diagram of the Cα
trace with every twentieth residue labelled. 
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Structure
dimethylbenzene ring is held in position by extensive van
der Waals contacts with the sidechains of Trp393 and
Thr402, whereas the pyrimidine ring is engaged in four H
bonds with backbone atoms (Figure 6). Moreover, the N5
atom is H-bonded with a tightly bound water molecule,
which is kept in position by an additional interaction with
the ε-amino group of Lys300 and with the carbonyl
oxygen of Gly57. An intriguing feature of the isoallox-
azine binding concerns the evident deviation from pla-
narity displayed by the flavin, which adopts a sort of
twisted conformation in both the native protein and in the
complex with MDL72527, with a 30° angle between the
pyrimidine and the dimethylbenzene rings (Figure 7). A
nonplanar conformation of the oxidised flavin is not
unprecedented and has been observed in other oxidases
such as cholesterol oxidase [17] and NADH oxidase [22].
Interestingly, in the case of PAO, the distortion of the
flavin makes the N5 atom point in the direction of the
substrate-binding site in the active-site tunnel (Figure 7).
This feature suggests that the nonplanar conformation
might be useful in precisely aligning the flavin N5 atom
with respect to the substrate.
The active centre
The PAO active centre consists of a remarkable ‘U-shaped’
tunnel, which passes through the protein structure at the
interface between the substrate- and FAD-binding
domains (Figures 5a and 5b). The tunnel extends for a
length of about 30 Å but the U shape brings its two open-
ings onto the same side of the protein surface, at a distance
of 16 Å from each other (measured by referring to Asp194
and Asn437). Furthermore, the width of the tunnel is fairly
constant along its path, with a diameter of 3.8–4.3 Å, as cal-
culated from the van der Waals surface of the protein
atoms lining the active centre.
The present description of the catalytic tunnel begins at
the entrance shown on the right-hand side of Figures 5a,
5b and 8. This opening is framed by several solvent-acces-
sible glutamate and aspartate sidechains (Asp117, Glu120,
Glu121 and Glu124 on Sα1, as well as Asp194 and Asp195
on loop Fα3–Fβ7), which form a sort of ‘carboxylate ring’
at the entrance of the tunnel (Figure 5b). Subsequently,
the tunnel, which is surrounded by several aromatic
residues, goes deep into the protein, leading to the core of
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Structure-based sequence alignment of maize PAO and human
monoamine oxidase A (MAO-A; accession code from the sequence
data base P21397), which is taken as a representative protein of
monoamine oxidases. The fingerprint motif characterising the
flavoprotein family identified by Dailey & Dailey [29] is shown, where U
is for hydrophobic residues and X is any residue. The label ‘flavin C8α’
outlines the position of residue Cys452, which in MAO-A is covalently
bound to the flavin C8α atom.
the catalytic site where the flavin ring is located. The
sidechains of Glu62 and Glu170 protrude in front of the
flavin, forming the turning point around which the tunnel
sharply bends and reverses its direction. These two car-
boxylate groups are within H-bonding distance of one
another (Figures 7 and 8), suggesting that the Glu62–
Glu170 pair is protonated. Another crucial element charac-
terising the innermost section of the catalytic tunnel is
built up by Phe403 and Tyr439. These two residues are
positioned parallel to each other and flank the tunnel on
opposite sides. In this way, they define a kind of ‘aromatic
sandwich’, which embraces the section of the active centre
located immediately after the tunnel U-turn (Figures 7
and 8). Finally, after Phe403 and Tyr439, the tunnel points
towards the protein surface (left-hand side in Figures 5a
and 8), being lined mainly by the carbonyl oxygen atoms of
several backbone peptide bonds in this region.
There is a marked contrast in the chemical nature of the two
arms of the U-shaped active centre. The right-hand-side
arm (Figures 5b and 8) is lined mainly by aromatic residues
and it opens to the outside like a funnel with several acidic
sidechains on its rim (Figure 5b). In contrast, the other arm
presents mostly oxygen atoms on its surface and it displays a
narrow entrance. This asymmetry in the chemical environ-
ment of the active centre suggests that the substrate might
be admitted into its binding site preferentially through only
one of the two tunnel openings. In this respect, the ring of
Asp and Glu residues, located on the right-hand-side
entrance (Figures 5b and 8), seems to be suited to fulfilling
the role of guiding the polyamine substrate into the tunnel.
Inhibitor binding
The substrate analogue MDL72527 (Figure 1c) competi-
tively inhibits PAO with Ki = 5.5 × 10–7 M (pH = 6.5,
25.0°C; RF, unpublished results). The electron-density
map unambiguously reveals the position of the inhibitor
(Figure 2). Ligand binding does not cause any significant
conformational change of the enzyme, with a rms deviation
of 0.11 Å from all Cα atoms of the native structure.
MDL72527 binds in the central part of the catalytic tunnel,
adopting a conformation that closely matches the shape of
the tunnel. This type of ‘lock-and-key’ binding mode
(Figure 5a) makes the inhibitor molecule completely
solvent-inaccessible. The bound inhibitor is involved in
extensive H-bond and van der Waals contacts with the sur-
rounding protein atoms (Figures 7 and 8). Moreover, it
interacts with the flavin ring, the shortest contact being the
3.8 Å distance between the flavin N5 and the inhibitor C8.
In fact, as a result of the tight packing between the cofactor
ring and the central diaminobutane unit of MDL72527
(Figure 1c), the flavin C4a–N5–C5a locus (Figure 6),
which in the ligand-free enzyme is solvent-accessible,
becomes shielded from the solvent upon inhibitor binding.
The N5 and N10 secondary amino groups of MDL72527 are
anchored to the protein by H bonds (Figure 7 and 8): N10 is
H-bonded to the sidechain of Tyr298, whereas N5 is within
H-bonding distance of the mainchain oxygen of Gly438.
Furthermore, the inhibitor N5 atom is positioned inside the
Tyr439–Phe403 aromatic sandwich and is thus able to estab-
lish favourable interactions with the electron-rich aromatic
rings [23]. A striking feature of the MDL72527 binding
mode is that six of the twelve inhibitor carbons are located
within 3.4 Å distance of protein oxygens. These belong to
either mainchain carbonyls (Phe171, Glu170, Ser404 and
Gly438) or sidechains (Asn405, Tyr439 and Glu62). With the
exception of C1, the carbon atoms involved in the these con-
tacts are either covalently bound (C4, C6, C9, C11, Figures 7
and 8) or separated by only two covalent bonds (C7) from
270 Structure 1999, Vol 7 No 3
Figure 5
The catalytic U-shaped tunnel of PAO. (a) The
drawing illustrates the solvent-accessible
surface of the tunnel, shown in chicken-wire
representation (red). The MDL72527 inhibitor
is depicted as a CPK model. The PAO
subunit has been rotated by 70° about the
vertical axis with respect to the orientation of
Figure 3a. (b) Electrostatic potential surface
of PAO. The molecule is approximately
represented in the same orientation as in (a),
so that the two entrances of the U-shaped
tunnel are in evidence. Positive and negative
potentials are represented in blue and red,
respectively. The scale of the surface display
ranges from –25 to +21 kT/e. The figure was
produced using the program GRASP [44].
(a) (b) Tunnel openings
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the inhibitor N5 and N10 amino groups. These
PAO–inhibitor interactions (see Figures 7 and 8) appear to
have the stereochemical characteristics of the so-called
CH...O H bonds (see [24] and references therein). This kind
of H bond has only recently been recognised as being of sig-
nificance in satisfying hydrogen-bonding potentials in pro-
teins and for stabilisation of DNA–protein interactions. In
particular, the ability of a methylene to act as a H-bond
donor is enhanced by the proximity to a polar or charged
atom such as an amino group [25].
The substrate-binding site of PAO is quite dissimilar from
that observed in the spermidine transporter protein [26]
and deoxyhypusine synthase [27], the only other spermi-
dine-binding proteins for which the crystal structure has
been determined. In these two proteins, the spermidine
primary amino groups are bound by acidic residues and no
interactions of the CH...O type have been described.
Implications for the catalytic mechanism
Polarised absorption microscopic studies have shown that
PAO crystals can be reduced by spermine and reoxidised
by air, thereby demonstrating that crystalline PAO is enzy-
matically active (A Mozzarelli, personal communication).
The precise mechanism by which the enzyme catalyses
the oxidation of the polyamine substrate is still unknown.
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Figure 6
Schematic drawing of the interactions
between FAD and the protein. Hydrogen
bonds are indicated by dashed lines. The
interatomic distances are in angstroms. W
indicates ordered water molecules.
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Structure
In this respect, the three-dimensional structure of PAO
reveals several relevant features. Firstly, the reaction takes
place in the solvent-protected environment provided by
the catalytic tunnel. Shielding the substrate from the
solvent is a feature shared by several flavin-dependent
oxidases and dehydrogenases [13]. Secondly, the structure
of the PAO–MDL72527 complex is essentially identical to
that of the native enzyme, implying that substrate binding
is unlikely to induce large conformational changes.
Thirdly, the water molecule that is H bonded to the flavin
N5 atom (Figures 6 and 7) seems well positioned to
perform the hydrolytic attack on the imino compound
resulting from polyamine oxidation to produce the final
aldehyde product (Figure 1a). Finally, the three-dimen-
sional structure shows that MDL72527 is a non-covalent
inhibitor of maize PAO. In this respect, the plant enzyme
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Figure 7
Stereoview of the mode of binding of
MDL72527 in the PAO active site. The
inhibitor is shown in ball-and-stick
representation. H bonds are represented by
dashed lines, whereas CH...O H bonds are
represented by dotted lines. Furthermore, the
contact between the MDL72527 C8 and the
flavin N5 is indicated by a dotted line. 
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Figure 8
Schematic representation of the catalytic
tunnel and inhibitor binding. The H bonds
between the inhibitor secondary amino groups
and the protein are represented by dashed
lines, whereas the CH...O H bonds are
represented by dotted lines. The 3.8 Å
contact between the inhibitor C8 and the
flavin N5 is outlined. The distances shown are
in angstroms.
HN NH
H2N O
HO
O O
3.0
2.9
3.42.9
2.8
3.0
2.9
2.8
2.72.6
O
Gly438
Phe403
Glu170
O
Ser404
Asn405
3.3
Tyr439
O
Phe171
O O
Glu62
Glu170
Trp60
Tyr165
Tyr 169
Phe89
Phe189
Tyr169
Tyr298
O
Glu124
Glu120
Asp194
Asp195Glu121
Asp117
N
N N O
O
O
2.9
1
2
3 4
5
6 7 8 9
10
11 12
13
14
3.8
OH
10
5 4a
Structure
differs from the mammalian PAO, which is covalently and
irreversibly inactivated by MDL72527 [28]. This differ-
ence in the mechanism of inhibition may be related to the
different specificities displayed by mammalian and plant
proteins (Figure 1b). An in-depth analysis of these obser-
vations must, however, await the determination of the
primary sequence of a mammalian PAO.
MDL72527 differs from spermine in that the two sper-
mine primary amino groups are replaced by a diene unit
(Figures 1b and 1c). Thus, the substrate primary amino
groups are strictly required by the enzyme in order to
catalyse substrate oxidation. The substrate primary nitro-
gen atoms are likely to bear a positive charge, which may
affect the protonation state and pKa value of the surround-
ing catalytic residues. Similarly, the positive charge of the
primary amino groups may influence the pKa value of the
substrate secondary amino groups, as suggested by the
observation that, in the PAO–MDL72527 complex, the
inhibitor N5 and N10 are at 4.6 Å and 4.0 Å distance from
the terminal C1 and C14 atoms, respectively (Figure 7).
Furthermore, the primary amino groups are likely to affect
the binding mode of the substrate. In the complex with
MDL72527, the flavin N5–C4a locus is at a distance of
more than 4.5 Å from the N5, C6, C9 and N10 atoms of
the inhibitor diaminobutane unit (Figures 7 and 8).
Regardless of  the type of mechanism, such a distance is
too long to allow oxidation by the flavin. Therefore the
position of the substrate within the catalytic tunnel is
probably shifted with respect to that of the inhibitor,
allowing a closer approach between the flavin and the sub-
strate C–N bond, which is oxidized by the enzyme.
Similarity between PAO and monoamine oxidase
Very recently, a new family of FAD-dependent proteins
has been identified by sequence alignment, which has
revealed a 50-residue long signature motif [29] (Figure 4).
This family encompasses oxidoreductases catalysing a
broad spectrum of reactions, such as protoporphyrinogen
oxidase, phytoene desaturase and monoamine oxidases.
Analysis of the amino acid sequence shows that PAO is also
a member of the family, as residues 7–57 match the family
signature motif. Particularly, the PAO three-dimensional
structure reveals that motif residues are involved in binding
the ADP-ribityl moiety of FAD. These observations imply
that members of the family possess a similar ADP-ribityl-
binding site, leading to the prediction that these proteins
share a topologically similar FAD-binding domain.
Monoamine oxidase (MAO) is a thoroughly investigated
flavoenzyme that binds to the outer mitochondrial mem-
brane and catalyses the oxidation of primary aromatic
amines (see [30] and references therein). The enzyme is
the target of drugs employed in the treatment of depres-
sive disorders and Parkinson’s disease [31]. Among the
members of the flavoenzyme family, MAO is of particular
interest because its homology with PAO extends beyond
the fingerprint motif [6] (Figure 4). In fact, in addition to
the amino acids involved in ADP-ribityl binding (Ser15,
Glu35, Ala36 and Arg43), several residues interacting with
the flavin (Lys300, Trp393 and residues on Fα8) are also
conserved among PAO and MAO primary sequences
(Figure 6). Furthermore, Thr402, which in PAO interacts
with the flavin C8α, is homologous to Cys452, which in
human MAO-A is located in the proximity of the flavin,
being covalently bound to the flavin C8α atom (Figure 4).
Taken together, these data suggest that PAO and MAO
are likely to share a similar overall folding topology and
FAD-binding site. However, on the basis of sequence
homology, this similarity does not extend to the substrate-
binding site. In fact, a survey of the PAO catalytic tunnel
reveals that some homology is detectable only in the aro-
matic-sandwich region surrounding the MDL72527 N5
atom (Figure 8): Gly438 and Tyr439 are conserved,
whereas Phe403 is replaced by Tyr in MAO. Such a low
similarity in the substrate-binding region is not surprising;
it reflects the different substrate specificities of the two
enzymes. In this respect, it will be interesting to see
whether the predicted partial structural similarity between
PAO and MAO reflects a common catalytic mechanism.
Biological implications
During recent years interest has been growing in natu-
rally occurring polyamines. These are linear molecules
with two (putrescine, NH2-(CH2)3-NH2), three (spermi-
dine, NH2-(CH2)3-NH-(CH2)4-NH2) or four (spermine,
NH2-(CH2)3-NH-(CH2)4-NH-(CH2)3-NH2) positively
charged nitrogen atoms. Polyamines are involved in a
variety of biological activities, ranging from the scaveng-
ing of free radicals to the specific regulation of proteins
such as certain protein kinases and DNA topoiso-
merases. In plants, polyamines are also involved in cell-
wall differentiation and in defence responses. The
polyamine intracellular level is finely controlled through a
network of pathways for the biosynthesis, degradation
and transport of these compounds. The discovery that
polyamine analogues have strong anticancer activity indi-
cates that enzymes involved in polyamine metabolism
may represent attractive targets for new anticancer drugs.
The FAD-dependent polyamine oxidase (PAO) plays a
central role in several physiological processes, including
polyamine homeostasis and cell death [8,11]. The
enzyme catalyses the degradative oxidation of the sec-
ondary amino groups of spermine and spermidine. Here,
we report the first crystal structure of PAO, which
reveals the remarkable architecture of enzyme active
site. PAO from Zea mays consists of two domains that
define a 30 Å long U-shaped tunnel at their interface.
The complex with the inhibitor MDL72527 reveals that
the innermost segment of the tunnel forms the enzyme
active site. The walls of this catalytic part of the tunnel
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are decorated by carbonyl oxygens, which extensively
interact with the snugly fitting inhibitor through unusual
CH...O H bonds.
MDL72527 differs from the spermine substrate only in
the absence of the primary amino groups. The three-
dimensional structure indicates that MDL72527 adopts a
kind of ‘out-of-register’ binding mode, in which the
inhibitor secondary nitrogen atoms are not properly
aligned with respect to the flavin in order for oxidation
by the cofactor to be possible. This feature provides the
basis for understanding the intriguing ability of PAO to
specifically oxidise a polyamine molecule that possesses
both primary and secondary amino groups.
The primary sequence of PAO shares homology with
members of a family of FAD-dependent oxidoreductases,
which includes protophorphirinogen oxidase and
monoamine oxidase. It can be predicted that members of
this family share a folding topology resembling that of
PAO. In particular, monoamine oxidase displays homol-
ogy to PAO throughout the sequence, implying that the
two enzymes are likely to have a similar FAD-binding site
and some conserved features in the active centre. These
observations provide the framework for protein engineer-
ing studies aimed at the characterisation of the catalytic
mechanism of these flavin-dependent amine oxidases.
Materials and methods
Crystallisation and crystal soaking
The purification and crystallisation protocols of maize PAO have been
described [32]. Briefly, the enzyme was crystallised by the hanging-
drop vapour-diffusion method, with the protein solution consisting of
5 mg enzyme/ml in 300 mM NaCl and 50 mM sodium phosphate buffer
(pH 6.0). The best crystals were obtained in two weeks at 293K by
mixing equal volumes of protein and reservoir solution, the latter con-
taining 42–48% saturated ammonium sulphate, 0.02% NaN3 and
100 mM sodium acetate buffer pH 4.6. Crystals belong to space group
P6522 with cell parameters a = b = 185 Å and c = 281 Å.
Two heavy-atom derivatives were obtained by soaking the crystal in
1 mM Pt(NH3)2Cl2 for 6 hours and in a UO2(CH3COO)2-saturated
mother liquor for 24 hours, respectively. Binding studies were per-
formed by soaking the crystals in a solution consisting of 60% satu-
rated ammonium sulphate in 100 mM acetate buffer (pH 4.6) plus
10 mM MDL72527 inhibitor.
Data collection
Data were collected at 100K [32] using cryocrystallographic techniques.
The native data used for phasing (native I in Table 2), the platinum and
uranyl derivative data were collected using a MarResearch imaging plate
detector at the X-ray diffraction beamline of ELETTRA (Trieste, Italy) and
at the X11 beamline of DESY/EMBL (Hamburg, Germany), respectively.
The native data used for refinement (native II) and the data for the
MDL72527 complex were measured at the ID14-EH3 beamline of ESRF
(Grenoble, France) using a MarCCD detector. In all cases, the images
were processed with MOSFLM (by AGW Leslie) and data reduction was
carried out using the CCP4 suite of programs [33].
MIR phasing
MIR phases were derived from the platinum and uranyl derivatives in
combination with the native I data set (Table 2). The Patterson super-
position option of SHELXS-97 [34] was used to identify four heavy-
atom sites for the uranyl derivative, which were then refined with the
program MLPHARE of the CCP4 package [33]. The resulting single
isomorphous replacement phases were used to calculate difference
Fourier maps, which provided four additional uranyl sites and revealed
the presence of four heavy-atom sites in the platinum derivative. The
platinum and uranyl sites were then refined together, resulting in MIR
phases having an overall figure of merit of 0.47 to 3.0 Å resolution. The
choice between the enantiomorphic P6122 and P6522 space-group
pairs and the assignment of the sign of the heavy-atom coordinates
was based on heavy-atom refinement statistics and the handedness of
the α helices in the electron-density map.
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Table 2
Data collection and phasing statistics.
Data set Native I Native II Pt(NH3)2Cl2 UO2(CH3COO)2 MDL72527
Cell axes a = b, c (Å) 184.7, 281.7 184.8, 282.2 184.8, 280.7 184.8, 297.8 184.6, 281.5
Number of crystals 1 1 1 1 1
Beamline ELETTRA ESFRF, ID14-EH3 ELETTRA DESY/EMBL, X11 ESRF, ID14-EH3
Detector Mar image plate Mar CCD Mar image plate Mar image plate Mar CCD
Maximum resolution (Å) 3.0 1.9 2.7 3.0 1.9
I/σ* 6.1 (5.8) 9.0 (2.6) 12.6 (9.4) 13.6 (9.9) 9.8 (3.5)
Observations 262,167 785,004 218,260 455,820 704,940
Unique reflections 55,695 216,570 74,309 50,430 211,025
Completeness (%)* 97.6 (88.9) 98.1 (88.4) 93.3 (78.2) 99.7 (96.8) 96.6 (95.2)
Rmerge (%)†* 9.4 (20.2) 8.2 (33.5) 4.2 (7.3) 5.9 (11.2) 8.8 (17.3)
Number of sites – – 5 8 –
Rderiv (%)‡ – – 15.5 22.5 18.2
Rcullis (%)§ – – 85 68 –
Phasing power# – – 0.54 1.13 –
*The values in brackets refer to the highest resolution shell.
†Rmerge = Σ | Ij – <Ij> | / Σ <Ij>, where Ij is the intensity of an observation
of reflection j and <Ij> is the average intensity for reflection j.
‡Rderiv = Σ || FPH | – | FP || / Σ | FP | where FPH is the structure factor for
the derivative or MDL72527-bound crystal and FP is the structure
factor of the native l crystal. §Rcullis = Σ || FPH ± FP | – FH | / Σ | FPH ± FP |
where FPH and FP are defined as above and FH is the calculated heavy-
atom structure factor. Centric reflections only were included for this
calculation. #Phasing power = the rms heavy-atom structure factor
amplitudes divided by the lack of closure.
Density averaging and model tracing
Considering the volume of the unit cell, the number of molecules in the
asymmetric unit could range from three to six, corresponding to a
solvent content of 71% to 42%, respectively. Various self rotation func-
tion calculations were performed using data at different resolution limits
and several values for the integration radius. However, a clear peak did
not appear in any of these calculations. For this reason, once the MIR
phases became available, solvent flattening was performed with the
program DM [33,35], increasing the solvent content from 30% to 80%
in steps of 5%. In all these solvent-flattening calculations, the same set
of reflections was used to monitor the free R factor [36], which dis-
played a minimum when the solvent fraction was set to 65%, suggest-
ing the presence of three subunits in the asymmetric unit. This feature
was confirmed by visual inspection of the solvent-flattened electron-
density map. In particular, a long helical segment (helix Sα1 in
Figure 5a) readily apparent in each of the three subunits allowed the
definition of the noncrystallographic-symmetry (NCS) operators. On the
basis of this, an envelope around the protein was calculated from a
local correlation map [37] and the MIR phases were refined and gradu-
ally extended to 3.0 Å by threefold averaging and solvent flattening
using the program DM [33,35]. The resulting map was of excellent
quality, allowing the building of the initial model by the program O [38].
Crystallographic refinement
The medium-resolution data set used to solve the structure thus far
was superceded at this point with a 1.9 Å resolution data set collected
at ESRF (Grenoble, France; Native II in Table 2). The initial model was
subjected to TNT [39] least-squares refinement alternated with manual
rebuilding [38]. A set of 2000 randomly chosen reflections was omitted
from refinement in order to calculate the free R factor. Strict NCS con-
straints were applied at the beginning, whereas NCS restraints were
used in the following refinement cycles. In the threefold-averaged map,
it was evident that the flavin ring was bent. Therefore planarity
restraints were applied only to the dimethylbenzene and pyrimidine
rings and not to the central ring of the isoalloxazine moiety.
The refined atom coordinates of the native enzyme were used as start-
ing point to determine the PAO–MDL72527 structure. After rigid-body
refinement, the presence of the bound inhibitor was detected as a clear
(> 3σ) difference density peak, which allowed the modelling of the
ligand molecule. The structure of the complex was then refined with the
TNT program and the same set of reflections as those for the native
structure were excluded in order to calculate the free R factor.
The PROCHECK [40] program was used to evaluate the stereochemi-
cal parameters of the refined structures. Atomic superpositions were
carried out using programs from the CCP4 package [33]. Surface and
volume calculations were performed with the program VOIDOO of the
‘Uppsala software factory’ [41]. The drawings were generated with the
program MOLSCRIPT [42]. The search through the data base of struc-
turally aligned proteins was carried out with the program DALI [43].
Accession numbers
The atomic coordinates and structure factors for native polyamine
oxidase and for the complex with MDL72527 have been deposited
with the Protein Data Bank under the accession codes 1b5q, r1b5qsf,
1b37 and r1b37sf, respectively.
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